A comprehensive view of gsk group (glaxosmithkline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
GSK announces partnerships with Second Harvest, FIRST Robotics, and Les Scientifines to expand support for community health, STEM education, and climate health in Canada; new partners were nominated by employees
Published:
April 18, 2024
by Canada Newswire
|
GlaxoSmithkline Biologicals Gets Patent for Process for the Manipulation of Nucleic Acids
Published:
April 18, 2024
by Biotechnology Patent News
|
GSK reports new long-term data show SHINGRIX vaccine continues to provide high protection against shingles in adults aged 50 and over for more than a decade
Published:
April 17, 2024
by GSK Group (GlaxoSmithKline)
|
GSK's 5-in-1 meningococcal ABCWY vaccine candidate accepted for review by the FDA; vaccine aims to provide broad protection against the five most common bacterial groups that cause invasive meningococcal disease
Published:
April 16, 2024
by GSK Group (GlaxoSmithKline)
|
GlaxoSmithkline Biologicals Seeks Patent for Adjuvants
Published:
April 13, 2024
by Pharmaceutical Patent News
|
Ask us about our Health Care Sector market view